Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy

Radiotherapy and Oncology

Volumn 109, Issue 3, 2013, Pages 487-492

  Rieken, Stefan ^a   Habermehl, Daniel ^a   Giesel, Frederik L ^a   Hoffmann, Christoph ^a   Burger, Ute ^a   Rief, Harald ^a   Welzel, Thomas ^a   Haberkorn, Uwe ^a   Debus, Jürgen ^a   Combs, Stephanie E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Boost irradiation; Delineation; FET; Glioma; Uniformity

Indexed keywords

GADOLINIUM; O (2 FLUOROETHYL)LEVO TYROSINE F 18; RADIOPHARMACEUTICAL AGENT; TEMOZOLOMIDE; UNCLASSIFIED DRUG; O-(2-((18)F)FLUOROETHYL)-L-TYROSINE; TYROSINE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; CONTRAST ENHANCEMENT; DRUG TUMOR LEVEL; FEMALE; GLIOMA; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; ION THERAPY; IRRADIATION; MALE; MULTIMODALITY CANCER THERAPY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHOTON THERAPY; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE; RADIATION DOSE ESCALATION; RADIOLOGICAL PARAMETERS; REPEAT PROCEDURE; TARGET VOLUME DEFINITION; TREATMENT PLANNING; TUMOR VOLUME; VOLUMETRY; ANALOGS AND DERIVATIVES; BRAIN NEOPLASMS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; INTENSITY MODULATED RADIATION THERAPY; MIDDLE AGED; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING; YOUNG ADULT;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED; TYROSINE; YOUNG ADULT;

EID: 84890122778     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.06.043     Document Type: Article

References (42)

1. D. Schulz-Ertner, and H. Tsujii Particle radiation therapy using proton and heavier ion beams J Clin Oncol 25 2007 953 964
2. G.L. Jiang Particle therapy for cancers: a new weapon in radiation therapy Front Med 6 2012 165 172
3. G. Kantor, and H. Loiseau Analysis of target volumes for gliomas Cancer Radiother 9 2005 230 239
4. G. Kantor, H. Loiseau, A. Vital, and J.J. Mazeron Gross tumor volume (GTV) and clinical target volume (CTV) in adult gliomas Cancer Radiother 5 2001 571 580
5. N. Laperriere, L. Zuraw, and G. Cairncross Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review Radiother Oncol 64 2002 259 273
6. B. Gulyas, and C. Halldin New PET radiopharmaceuticals beyond FDG for brain tumor imaging Q J Nucl Med Mol Imaging 56 2012 173 190
7. M. Rapp, A. Heinzel, and N. Galldiks Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma J Nucl Med 54 2013 229 235
8. D.C. Weber, T. Zilli, and F. Buchegger [(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma Radiat Oncol 3 2008 44
9. A.L. Grosu, S.T. Astner, and E. Riedel An interindividual comparison of O-(2-[18F] fluoroethyl)-l-tyrosine (FET)- and l-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases Int J Radiat Oncol Biol Phys 81 2011 1049 1058
10. M. Niyazi, O. Schnell, and B. Suchorska FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status Radiother Oncol 104 2012 78 82
11. M.D. Piroth, R. Holy, and M. Pinkawa Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy Radiother Oncol 99 2011 218 224
12. A.L. Grosu, M. Molls, and F.B. Zimmermann High-precision radiation therapy with integrated biological imaging and tumor monitoring: evolution of the Munich concept and future research options Strahlenther Onkol 182 2006 361 368
13. A.L. Grosu, W.A. Weber, and S.T. Astner 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy Int J Radiat Oncol Biol Phys 66 2006 339 344
14. I.H. Lee, M. Piert, and D. Gomez-Hassan Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme Int J Radiat Oncol Biol Phys 73 2009 479 485
15. P. Mahasittiwat, J.E. Mizoe, and A. Hasegawa l-[methyl-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy Int J Radiat Oncol Biol Phys 70 2008 515 522
16. S.E. Combs, M. Kieser, and S. Rieken Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial BMC Cancer 10 2010 478
17. S. Rieken, D. Habermehl, T. Haberer, O. Jaekel, J. Debus, and S.E. Combs Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts Radiat Oncol 7 2012 41
18. S.E. Combs, I. Burkholder, and L. Edler Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial BMC Cancer 10 2010 533
19. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
20. M. Niyazi, J. Geisler, and A. Siefert FET-PET for malignant glioma treatment planning Radiother Oncol 99 2011 44 48
21. S.E. Combs, M. Ellerbrock, and T. Haberer Heidelberg Ion Therapy center (HIT): initial clinical experience in the first 80 patients Acta Oncol 49 2010 1132 1140
22. M.W. McDonald, H.K. Shu, W.J. Curran Jr., and I.R. Crocker Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma Int J Radiat Oncol Biol Phys 79 2011 130 136
23. K. Nakagawa, Y. Aoki, and T. Fujimaki High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme Int J Radiat Oncol Biol Phys 40 1998 1141 1149
24. K. Petrecca, M.C. Guiot, V. Panet-Raymond, and L. Souhami Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma J Neurooncol 111 2013 19 23
25. D. Amelio, S. Lorentini, M. Schwarz, and M. Amichetti Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues Radiother Oncol 97 2010 361 369
26. G. Minniti, D. Amelio, and M. Amichetti Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide Radiother Oncol 97 2010 377 381
27. A.L. Grosu, and W.A. Weber PET for radiation treatment planning of brain tumours Radiother Oncol 96 2010 325 327
28. A.L. Grosu, M. Piert, and W.A. Weber Positron emission tomography for radiation treatment planning Strahlenther Onkol 181 2005 483 499
29. A.L. Grosu, W.A. Weber, and M. Franz Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy Int J Radiat Oncol Biol Phys 63 2005 511 519
30. A.L. Grosu, W.A. Weber, and E. Riedel l-(Methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy Int J Radiat Oncol Biol Phys 63 2005 64 74
31. M.W. Gross, W.A. Weber, H.J. Feldmann, P. Bartenstein, M. Schwaiger, and M. Molls The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas Int J Radiat Oncol Biol Phys 41 1998 989 995
32. D. Pauleit, F. Floeth, and K. Hamacher O-(2-[18F]fluoroethyl)-l-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas Brain 128 2005 678 687
33. M.D. Piroth, M. Pinkawa, and R. Holy Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study Strahlenther Onkol 188 2012 334 339
34. S.T. Astner, M. Dobrei-Ciuchendea, and M. Essler Effect of (11)C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas Int J Radiat Oncol Biol Phys 72 2008 1161 1167
35. M. Matsuo, K. Miwa, and O. Tanaka Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning Int J Radiat Oncol Biol Phys 82 2012 83 89
36. A. Fiorentino, R. Caivano, P. Pedicini, and V. Fusco Clinical target volume definition for glioblastoma radiotherapy planning: magnetic resonance imaging and computed tomography Clin Transl Oncol 2013 [epub ahead of print]
37. S. Fanti, M. Farsad, and L. Mansi PET-CT beyond FDG a quick guide to image interpretation Springer 1 2010 1 243
38. D.C. Weber, N. Casanova, and T. Zilli Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study Radiother Oncol 93 2009 586 592
39. W. Schlegel If you can't see it, you can miss it: the role of biomedical imaging in radiation oncology Radiat Prot Dosimetry 139 2010 321 326
40. M. Van Kampen, S. Levegrun, and M. Wannenmacher Target volume definition in radiation therapy Br J Radiol 70 1997 S25 S31
41. M. Niyazi, A. Siefert, and S.B. Schwarz Therapeutic options for recurrent malignant glioma Radiother Oncol 98 2011 1 14
42. J. Bauer, D. Unholtz, and F. Sommerer Implementation and initial clinical experience of offline PET/CT-based verification of scanned carbon ion treatment Radiother Oncol 107 2013 218 226